This article is for general educational purposes and is not medical or financial advice; consult your pharmacist or prescriber before changing how you fill a prescription. Unless noted inline, figures reflect 2024–2026 data from the named primary sources.
TL;DR — Quick Verdict
- A 90-day supply of atorvastatin 40mg runs about $8.63 through Cost Plus Drugs versus roughly $68.99 as a CVS cash price — an 87% gap for the identical generic.
- GoodRx users saved 83% off retail cash prices on average in 2024, per GoodRx; a peer-reviewed study found its median coupon price was 67% below retail cash.
- Cost Plus Drugs uses one formula — manufacturer cost + 15% markup + a pharmacy fee + shipping — and wins on single generics but only pays off when you bundle 90-day fills.
- TrumpRx, launched February 5, 2026, discounts only brand-name drugs for cash payers; 9 in 10 U.S. prescriptions are generic, per the FDA, so most people save more elsewhere.
- Recommendation: price every maintenance generic across insurance copay, Cost Plus Drugs, and a discount card before you refill — the cheapest channel changes drug by drug.
Americans spent $467.0 billion on retail prescription drugs in 2024, according to the Centers for Medicare & Medicaid Services — yet the price any one patient pays for a given pill can swing by a factor of ten depending on nothing more than which checkout they use. A 30-day supply of generic atorvastatin 20mg might ring up at $4.12 at Costco and $17.89 at a nearby CVS in the same ZIP code on the same day, according to pricing analysis from HealthRX. The problem is not that drugs are uniformly expensive; it is that the market hides five or six parallel prices for the same molecule and rarely shows them side by side. This article maps those channels — retail cash, insurance copay, GoodRx and other discount cards, Mark Cuban’s Cost Plus Drugs, mail-order and Amazon Pharmacy, and the new federal TrumpRx portal — with real dated prices, the math behind each model, and a decision framework for which one wins for your specific prescription. Cost Plus Drugs and GoodRx anchor most of the comparisons because they represent the two dominant strategies: transparent cost-plus pricing versus negotiated coupon discounts.
What the Same Generic Costs Across Six Channels
Start with the numbers, because they make the argument better than any explanation. The table below tracks three of the five most-prescribed generics in the United States — atorvastatin, metformin, and lisinopril — across the channels most patients actually reach for. Prices are 90-day equivalents where the channel sells that way, and each is drawn from a dated 2026 source audit.
Cost Plus Drugs and GoodRx figures compiled from RxGrab and HealthRX 2026 multi-pharmacy audits; retail cash reflects chain-pharmacy list prices. Metformin/lisinopril GoodRx and retail ranges reflect ZIP-code variation — provider-specific point prices were unavailable. Verify current prices at costplusdrugs.com and goodrx.com.
Two patterns jump out. On the cheapest, most competitive generics, every discount channel lands within a few dollars of the others, and the retail cash price is the outlier — a number almost no informed shopper should ever pay. On drugs where pharmacy benefit managers have historically inflated the spread, such as metformin and lisinopril, the gap between the transparent price and the cash counter widens dramatically. This is where using hospital price transparency tools and their retail-pharmacy equivalents earns its keep.
How Cost-Plus Pricing Actually Works
Cost Plus Drugs prices every product with one visible formula: the manufacturer’s acquisition cost, plus a flat 15% markup, plus a pharmacy fee, plus shipping. Company statements and independent audits confirm the 15% markup; the pharmacy fee is reported as $5 per order in most 2026 sources, with shipping starting around $5.25. That transparency is the entire pitch — no PBM rebate, no negotiated rate that shifts quarterly, no location-based variability.
Walk through a real fill. A 90-day supply of atorvastatin costs roughly $3.63 in drug cost. Add the pharmacy and shipping fees and the total lands near $8.63, or about $2.96 a month. That is genuinely lower than a typical GoodRx monthly equivalent. But the fee structure carries a trap: order a single $3.90 atorvastatin by itself and your real cost climbs to nearly $13.90 once fees load on — at which point Walmart’s $4 generic program wins for a one-drug patient, per RxGrab’s audit.
The model rewards consolidation. Because shipping is tiered — roughly $5.25 for one to two prescriptions, $7.50 for three to four — a patient bundling four 90-day maintenance drugs into one order spreads that single fee across every medication. The more you consolidate, the better the per-drug math. This is the opposite of the retail counter, where each fill is priced in isolation, and it mirrors the logic behind comparing reference lab versus hospital lab pricing: the delivery channel, not the underlying product, drives most of the cost.
How GoodRx and Discount Cards Set Their Prices
Discount cards work on a fundamentally different mechanism. GoodRx does not sell drugs; it aggregates the cash prices that pharmacy benefit managers have already negotiated with individual pharmacies, then hands you a coupon to pay that discounted rate instead of the sticker cash price. Because those PBM-pharmacy contracts differ store by store and shift quarterly, GoodRx prices are not fixed — the same atorvastatin 20mg can show $4.12 at one chain and $17.89 at another blocks away.
The headline savings are real but uneven. GoodRx reports users saved 83% off retail cash prices on average in 2024, and a 2023 study in the Journal of the American Pharmacists Association found its median coupon price ran 67% below median retail cash for the 50 most-prescribed generics. Generics show the deepest discounts; brand-name and specialty drugs show little or none. For GLP-1 agonists like Ozempic, coupons trim only single-digit to low-double-digit percentages off list prices that exceed $900 a month, per Kaiser Family Foundation analysis.
One structural caveat separates this channel from insurance: GoodRx and Cost Plus purchases do not count toward your deductible or out-of-pocket maximum. If you are on track to hit that ceiling — say, during an expensive treatment year — routing spending through a coupon can quietly cost you more overall, the same trade-off that surfaces in inpatient versus outpatient status cost differences.
Cost Plus Drugs vs. GoodRx: Which Is Better for Maintenance Medications?
These two channels split the market cleanly, and the deciding factor is timing, not brand loyalty. GoodRx shines when you need a prescription filled today at a local pharmacy — an antibiotic, a short course, a controlled substance that mail-order cannot legally ship. Cost Plus Drugs shines for chronic maintenance drugs you take every day and can plan five to ten business days ahead to receive by mail.
Run the annual math on a common three-drug profile — lisinopril, atorvastatin, and metformin. RxGrab’s audit found a hybrid approach, using Cost Plus for 90-day maintenance fills, saved about $2,783 a year versus retail and came out roughly $16 to $29 ahead of a GoodRx-only strategy for that basket. The gap is modest on ultra-cheap generics but widens sharply on moderately priced ones, where Cost Plus prices averaged 67% below GoodRx coupon prices across the audited drugs that both platforms list.
Verdict
For stable, long-term maintenance generics, bundle 90-day supplies through Cost Plus Drugs — the transparent price plus a single spread-out shipping fee usually wins. For same-day fills, controlled substances, or one-time courses, use GoodRx at a nearby pharmacy. Most patients on multiple chronic drugs are best served running both: Cost Plus for the standing regimen, GoodRx for the occasional acute prescription. Neither counts toward a deductible, so insured patients near their out-of-pocket max should still price the insurance copay first.
Where TrumpRx Fits — and Where It Doesn’t
Launched February 5, 2026, TrumpRx.gov added a sixth channel to the mix, and it is widely misunderstood. The federal platform is not a pharmacy; like GoodRx, it is a lookup portal that shows cash-paying, uninsured patients discounts on select brand-name drugs and routes them to manufacturer direct-to-consumer programs. At launch it listed roughly 40 to 43 medications from a handful of manufacturers, concentrated in high-cost categories: GLP-1 weight-loss drugs, fertility injectables, and insulin.
The scope is the catch. TrumpRx discounts brand-name drugs only, and the White House itself notes that 9 in 10 U.S. prescriptions are generic, per the FDA, while about 84% of Americans already hold prescription coverage, per HHS. For the routine generics most people fill, a covered copay, a discount card, or Cost Plus typically beats a brand-name cash price. The platform’s clearest value is narrow: an uninsured patient needing a specific listed brand drug — say, a GLP-1 the administration says dropped from over $1,000 to $199 — with no generic alternative available.
Independent analysts caution that insured patients paying cash through the site could end up spending more than their copay when cheaper covered or generic options already exist. The disciplined move is the same one that applies to price shopping elective procedures: treat it as one quote among several, never the default.
What Most People Get Wrong About Buying Prescriptions
Even careful shoppers repeat the same avoidable errors. Each one has a concrete cost and a concrete fix.
Assuming insurance always wins. Many patients hand over their card reflexively. The consequence: for a low-cost generic, the coupon or cash price frequently beats the copay outright, and running it through insurance can cost more. The fix — tell the pharmacist to process it as cash with your GoodRx coupon and compare before you decide, a habit that pairs naturally with reviewing finding and disputing medical billing errors.
Filling 30 days at a time on maintenance drugs. Short fills multiply per-order fees and trips. The consequence is paying the shipping or dispensing charge four times as often as necessary. The fix: switch chronic medications to 90-day supplies so fixed fees spread across three months of pills.
Forgetting the deductible trade-off. Coupon and Cost Plus spending is invisible to your insurance ledger. If you are heading toward your out-of-pocket maximum during a costly year, the consequence is a higher total bill. The fix: when big spending is coming, prioritize the channels that accrue toward your out-of-network billing protections and cost ceiling.
Ignoring the $4 generic programs. Walmart, Costco, and select grocery chains price a list of common generics at roughly $4 for 30 days — often beating every card. Skipping them means overpaying on the cheapest drugs. The fix: check those flat lists first for the ten or so most-prescribed generics.
Which Channel Is Worth It for Your Situation?
The right channel is conditional, and a few clean rules cover most cases. If you are uninsured and take chronic generics, Cost Plus Drugs almost always delivers the lowest total cost, provided you can wait for mail delivery and bundle your fills. If you have insurance with low Tier 1 copays and are approaching your out-of-pocket maximum, use insurance so the spending counts.
If you need a drug today, or a controlled substance that mail-order cannot ship, GoodRx or SingleCare at a local pharmacy is the practical choice — and worth comparing against the store’s own cash price, since discount cards sometimes lose to Walmart or Costco flat pricing. If you are uninsured and need a specific brand-name drug with no generic, that is the one scenario where TrumpRx or a manufacturer copay program may be your best option, especially in the high-cost GLP-1 and fertility categories those programs target.
The through-line is that no single channel wins every time. A patient on four maintenance generics plus an occasional brand drug might rationally use Cost Plus, insurance, GoodRx, and a manufacturer program in the same month. Building that five-minute comparison habit — the same discipline behind hospital bill negotiation strategies — is what converts the market’s hidden price spread from a liability into leverage.
Frequently Asked Questions
Can I use GoodRx and insurance together?
No — you choose one per fill. GoodRx is a cash-price coupon, so the pharmacist either bills your insurance or applies the coupon, not both. GoodRx purchases do not count toward your deductible or out-of-pocket maximum. The practical move is to ask the pharmacist to quote both, then pick the lower number, keeping in mind that only the insurance path advances you toward your annual cost ceiling.
Does Cost Plus Drugs accept insurance?
No. Cost Plus Drugs does not bill insurance; you pay its transparent cash price of manufacturer cost plus a 15% markup, a pharmacy fee, and shipping. You can submit receipts to an HSA or FSA, but the spending will not apply toward your plan’s deductible. For patients with very low copays on covered drugs, insurance may still be the cheaper route, so compare before switching.
Why is the same drug so much cheaper at some pharmacies?
Because pharmacy benefit managers negotiate different cash rates with each pharmacy, and those contracts shift quarterly. HealthRX documented generic atorvastatin 20mg showing $4.12 at one chain and $17.89 at another in the same ZIP code on the same day. Transparent channels like Cost Plus Drugs avoid this by pricing off one published formula, which is why their prices stay stable regardless of location.
Is TrumpRx cheaper than my insurance?
Usually not, if you are insured. TrumpRx, launched February 5, 2026, discounts only brand-name drugs for cash payers, and the White House notes 9 in 10 U.S. prescriptions are generic, per the FDA. For covered generics, your copay or a discount card typically beats a brand cash price. TrumpRx mainly helps uninsured patients who need a specific listed brand drug with no generic alternative.
How We Researched This Article
This analysis draws on primary government data, peer-reviewed research, and dated multi-pharmacy price audits, layered to separate measured prices from modeled scenarios. National spending figures come directly from the Centers for Medicare & Medicaid Services National Health Expenditure data, which reported retail prescription drug spending of $467.0 billion in 2024. Pricing-model details for Cost Plus Drugs were verified against the company’s own published formula and cross-checked with independent 2026 audits; the launch scope and mechanics of TrumpRx were confirmed against the official White House fact sheets and contemporaneous reporting.
Channel-level drug prices are a blend of measured and modeled figures. Point prices for atorvastatin, metformin, and lisinopril were pulled from dated 2026 audits by RxGrab and HealthRX and from GoodRx’s own listings; where a single provider price was unavailable, we present a defensible range and label it as such. Annual-savings scenarios (for example, the roughly $2,783 hybrid-strategy figure) are modeled from those audited unit prices applied to a standard three-drug maintenance profile, not measured from a single patient’s bills. GoodRx’s 83% average-savings claim reflects the company’s 2024 self-reported data; the independent 67% median figure comes from a peer-reviewed study.
Key limitations: retail cash and coupon prices vary by ZIP code, pharmacy, and week, so any figure here is a snapshot rather than a guarantee, and readers should verify current prices before filling. Formularies, fees, and TrumpRx’s drug list are all expanding and may have changed since publication. Primary sources include the CMS National Health Expenditure Fact Sheet, the White House TrumpRx launch fact sheet, and the U.S. Food and Drug Administration generic drugs resource. This research was last conducted in July 2026. All figures were verified against named primary sources before publication.